Medtronic (NYSE: MDT) announced today that it received CE mark approval for its BrainSense adaptive deep brain stimulation ...

Medtronic CEO Geoff Martha discusses innovations such as pulse field ablation, renal denervation, DBS, TAVR, diabetes tech ...

While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now ...

1 Medtronic has been at the forefront of DBS therapy since 1987, with over 185,000 DBS devices implanted worldwide. The NeuroSmartTM Portable MER Navigation system, developed by Alpha Omega ...

Medtronic’s BrainSense aDBS is a therapy intended to improve the quality of life for individuals living with Parkinson’s ...

Medtronic is the originator of continuous deep brain stimulation (cDBS), which has been available for decades as a proven ...

Currently, the Medtronic Access controller is the most commonly used DBS patient controller. In practice, we observed that especially elderly patients refuse to use the controller or encounter ...

(RTTNews) - Medtronic plc (MDT), Monday said it received CE Mark approval for its BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier in the European Union and the ...

New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, ...